ArticleRSC advances2025
Preparation of cobalt based metal organic framework ZIF-67 catalyst for activating peroxymonosulfate and its catalytic system for rapid degradation of Rhodamine B and other dyes at high concentrations.
Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Concentrated sulfuric acid-assisted synthesis of tubular g-CRSC advances · 2026Article
- Preparation of mesoporous nanosphere SiORSC advances · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Persistent organic pollutants pose significant long-term risks to environmental and human health due to their carcinogenic, mutagenic, and teratogenic properties. This study focuses on the efficient activation of peroxymonosulfate (PMS) through the rational design of a cobalt-based metal-organic framework (ZIF-67) catalyst, enabling rapid degradation of high-concentration dye pollutants. By optimizing the molar ratio of 2-methylimidazole (2-MeIM) to Co(NO
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.